-
Marchés
-
Actions
Sustainable finance2025 Euronext ESG Trends ReportLire la suiteA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLire la suiteInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fonds
-
Obligations
European Defence BondsGroupe BPCE lists the first bondLire la suiteFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Produits Structurés
-
Dérivés
Where European Government Bonds Meet the FutureFixed Income derivativesLire la suiteTrade mini bond futures on main European government bonds
-
Marchandises
- Vue d'ensemble
- Vue d'ensemble
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Règlement livraison
- Spécifications et dispositions
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLire la suiteEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLire la suiteJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
ORAGENICS
Identification
Listing sponsor / Agent
BRYAN, GARNIER AND CO Ltd
Symbole
ALONI
Code ISIN
US6840231046
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
Biotechnology
Site internet
http://www.onibiopharma.com
Issuer website
http://www.onibiopharma.com
Operation
Date de l'IPO
lun 15/12/2008
IPO type
Cotation directe
Type d'IPO
Initial Public offering
Catégorie
IPO
Operation procedure
- Nombre de titres à admettre : 38 318 478 - Cours de référence : cours de clotûre de l'action Oragenics du 12/12/2008 sur NYSE Alternext US, converti en EUR selon le taux de change du 12/12/2008.
Operation description
Admission sur Alternext des 38 318 478 actions ordinaires composant le capital de la société
ORAGENICS. La société ORAGENICS, dont le nom commercial est ONI BioPharma, est par ailleurs cotée sur NYSE Alternext US.
Operation calendar
15 décembre 2008 : admission aux négociations des actions émises par ORAGENICS